Sponsor:
Actinium Pharmaceuticals
Code:
NCT03867682
Conditions
Acute Myeloid Leukemia
Relapsed Adult AML
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lintuzumab-Ac225
Venetoclax
Spironolactone
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations